Download the Protocol

BPC-157

BPC-157 is a short chain of amino acids found to help the body repair itself. It supports the healing of muscles, joints, and the gut, helping reduce inflammation and speed up recovery. It does not act like a hormone, but rather helps tissues recover more efficiently.

Description

• BPC-157 is a synthetic peptide made of 15 amino acids derived from a natural protein found in the stomach.
• Studied for its ability to support healing, reduce inflammation, and protect tissues.
• Often researched for use in muscle, tendon, and gut recovery.

How It Works

• Supports growth of new blood vessels and tissue repair.
• Promotes collagen production in muscles, ligaments, and tendons.
• Protects the stomach and gut lining from stress or injury.

Documented Effects

• Accelerates healing of muscles, ligaments, and tendons in animal models.
• Reduces inflammation and swelling in soft tissue injuries.
• Improves recovery from gut and intestinal damage in research settings.
• Shows protective effects on nerves and the cardiovascular system in studies.

Theoretical Effects

• May help maintain joint flexibility and mobility with repeated use.
• Potential benefits for bone and nerve repair based on preclinical data.
• No confirmed therapeutic outcomes in large-scale human trials.

Pharmacokinetics

• Half-life: approximately 4–6 hours after subcutaneous injection.
• Time to peak concentration: about 30–90 minutes post-injection.
• Steady-state: reached within 2–3 days of consistent daily use.

Duration of Effects

• Local repair activity persists up to 12–24 hours post-dose.
• Cumulative healing benefits increase with continued daily use over weeks.
• Effects gradually decline within a few days of stopping.

Reconstitution

• Use only bacteriostatic water to mix the lyophilized powder.
• Example vial: 10 mg of BPC-157
• Choose reconstitution volume based on dosing convenience:
  • 1 mL water → 10 mg/mL → 1 mg per 10 units
  • 2 mL water → 5 mg/mL → 500 mcg per 10 units
• Swirl gently to dissolve; avoid shaking.
• Refrigerate reconstituted solution (2–8 °C). Use within ~21 days for best stability.

Injectable Dosage Overview (First-Time Use)

Typical Starting Dose

• Injectable (off-label, anecdotal): ~200–500 mcg subcutaneous (SC) once daily
• Conservative entry point: start at ~200 mcg to assess tolerance

Common Therapeutic Range

• Injectable reports: 250–500 mcg SC daily → up to ~1 mg/day in intensive protocols
• Used primarily for tendon, ligament, or gut tissue recovery.

Maximum Daily Dose

• Anecdotal ceiling: ~1 mg/day SC
• Higher doses (>1 mg) lack human data and show no clear added benefit

Standard Cycle Length

• Light use: 2–4 weeks continuous, then evaluate
• Therapeutic use: 4–6 weeks on → 2–4 weeks off before repeating if indicated

Clinical Notes

• Inject subcutaneously near the injury site for targeted effect.
• No tapering required; can stop abruptly once healing is achieved.
• May be combined with TB-500 for broader tissue recovery support.
• Stable for about 21 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing.

Safety Notes (First-Time Use)

• Begin low (~0.2 mg / 200 mcg SC) and increase gradually if tolerated
• Possible effects: mild redness or soreness at injection site
• Maintain sterile injection technique and confirm peptide purity
• Do not stack with unverified compounds
• Long-term human safety data remain limited